Jacobs Levy Equity Management, Inc Caribou Biosciences, Inc. Transaction History
Jacobs Levy Equity Management, Inc
- $23.9 Billion
- Q1 2025
A detailed history of Jacobs Levy Equity Management, Inc transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,442,121 shares of CRBU stock, worth $1.24 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,442,121
Previous 1,208,069
19.37%
Holding current value
$1.24 Million
Previous $1.92 Million
31.67%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRBU
# of Institutions
135Shares Held
47MCall Options Held
17.1KPut Options Held
58.1K-
Black Rock Inc. New York, NY6.95MShares$5.98 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$3.89 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.27MShares$2.81 Million0.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA2.51MShares$2.16 Million0.18% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY2.35MShares$2.02 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $52.3M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...